TEVA Files NDA With FDA for Olanzapine LAI for Schizophrenia
Teva files an NDA seeking FDA approval for its once-monthly olanzapine LAI for the treatment of adults with schizophrenia.
Zacks·1d ago
More News
Teva Stock Trading Above 200- & 50-Day SMA for 2 Months: How to Play
Teva holds bullish momentum, trading above key SMAs, as branded drugs and biosimilars drive growth despite generics softness.
Zacks·2d ago
Teva Stock Trading Above 200- & 50-Day SMA for 2 Months: How to Play
Teva holds bullish momentum, trading above key SMAs, as branded drugs and biosimilars drive growth despite generics softness.
Zacks·2d ago
Teva Stock Trading Above 200- & 50-Day SMA for 2 Months: How to Play
Teva holds bullish momentum, trading above key SMAs, as branded drugs and biosimilars drive growth despite generics softness.
Zacks·2d ago
KYMR Stock Surges on Upbeat Data From KT-621 Atopic Dermatitis Study
Kymera jumps after phase Ib study data show KT-621 delivers strong STAT6 degradation and broad clinical activity in patients with atopic dermatitis.
Zacks·2d ago
KYMR Stock Surges on Upbeat Data From KT-621 Atopic Dermatitis Study
Kymera jumps after phase Ib study data show KT-621 delivers strong STAT6 degradation and broad clinical activity in patients with atopic dermatitis.
Zacks·2d ago
Sanofi $SNY Shares Sold by London & Capital Asset Management Ltd
London & Capital Asset Management Ltd lessened its stake in shares of Sanofi (NASDAQ:SNY - Free Report) by 69.9% in the 2nd quarter, according to its most recent 13F filing with the Securities and...
MarketBeat·2d ago
Sanofi $SNY Shares Sold by London & Capital Asset Management Ltd
London & Capital Asset Management Ltd lessened its stake in shares of Sanofi (NASDAQ:SNY - Free Report) by 69.9% in the 2nd quarter, according to its most recent 13F filing with the Securities and...
MarketBeat·2d ago
Sanofi $SNY Holdings Boosted by First Trust Advisors LP
First Trust Advisors LP raised its stake in Sanofi (NASDAQ:SNY - Free Report) by 14.8% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange...
MarketBeat·2d ago
Sanofi $SNY Holdings Boosted by First Trust Advisors LP
First Trust Advisors LP raised its stake in Sanofi (NASDAQ:SNY - Free Report) by 14.8% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange...